Compass Pathways has announced an accelerated timeline for the potential approval of its psilocybin-based treatment for severe depression. The company indicated on Tuesday that it now...
The U.S. Food and Drug Administration (FDA) is preparing to implement additional deregulation measures, as indicated by Commissioner Marty Makary. In statements made this week, Makary...
Cogent Biosciences, Inc. has presented updated preclinical data on its pan KRAS(ON) inhibitor during a poster session at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets...
The U.S. Food and Drug Administration (FDA) has announced the first group of drugs that will undergo expedited review processes. This initiative is part of a...
Concerns are mounting over the United States’ heavy dependence on foreign-made generic drugs, particularly following reports linking this reliance to the deaths of over 100 individuals....
Namandje Bumpus, the former principal deputy commissioner of the U.S. Food and Drug Administration (FDA), has been appointed to lead a new scientific advisory board at...
Namandje Bumpus, the former principal deputy commissioner of the U.S. Food and Drug Administration (FDA), has been appointed to lead a new scientific advisory board at...
Acadia Pharmaceuticals has announced an indefinite delay in its plans to seek approval for its Rett syndrome drug, Daybue, in the United Kingdom. This decision stems...
An estimated 10,000 ankle replacements are performed annually in the United States. A surgeon from New York City has introduced a patented technique that aims to...
The Swedish biopharmaceutical company Alzinova has received approval from the U.S. Food and Drug Administration (FDA) to advance its Alzheimer’s vaccine candidate, ALZ-101, into a Phase...
